Dr. Ramadan Abdelaziz, radiation biologist and molecular biology researcher whose work focuses on radiation biology, and molecular mechanisms influencing cancer therapy response. currently serves as a Radiation Biology Consultant at the International Atomic Energy Agency (IAEA), in Vienna, Austria. In this role, he contributes to international initiatives in radiation medicine and biodosimetry. He contributed as reviewer, co-author, and corresponding author to major international guidance documents, including Setting Up a Cancer Centre: A WHO–IAEA Framework (2022) and the Guidance on Setting Up a Comprehensive Cancer Centre (2024), developed jointly by the World Health Organization and the IAEA to support the development of comprehensive cancer care infrastructure worldwide and Radiation Detectors and Methods in Medicine Therapy, Diagnostic and Radiation Protection book. Obtained his PhD in Pharmaceutical Sciences (Radiation Biology) from the University of Vienna with distinction. His doctoral research investigated the molecular role of cysteine cathepsins in modulating tumor response to radiation and explored potential therapeutic strategies to improve cancer treatment efficacy.
International Atomic Energy Agency
Vienna, Wien, Austria
NA